Home Tags Drug Development

Drug Development Related Content

Alzheimer's brain, Alzheimer's disease research

Scientists reveal largest ever map of human Alzheimer’s brain

On the 4th February 2019, a scientific breakthrough for the future of Alzheimer's brain reserach has been published - read on to explore the developments.
UCL Translational office

UCL Translational Research Office (TRO)

UCL’s Translational Research Office (TRO) builds on an increasingly vibrant translational culture across the university community.
opioids for pain, poor areas

GPs prescribe more opioids for pain in poor Northern areas, study reveals

English patients living in poorer areas are likely to be prescribed more opioids for pain by their GPs, according to a study led by University of Manchester and University of Nottingham researchers.
Neuromuscular disease

Advances in newborn screening for neuromuscular disease

Kristin Stephenson, Sr. VP, Chief Policy & Community Engagement Officer at the Muscular Dystrophy Association details the advances taking place in newborn screening for neuromuscular disease
Organoids

Developmental biology: Fulfilling the promise of Organoids

Professor of Developmental Mechanics at the Department of Genetics, University of Cambridge, Alfonso Martinez Arias shares his expert view on Organoids, within the field of developmental biology.
Cancer therapy

The current and future challenges of personalised cancer therapy

Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers.
drug innovation

ISOTOPICS, a European project for de-risking drug innovation

Christophe Dugave & Karen Hinsinger from CEA-Saclay highlight an exciting European research project for de-risking drug innovation, ISOTOPICS
Heterocyclic

The changing face of Heterocyclic Chemistry in the pharmaceutical industry

Professor of Organic Chemistry at University of York and Chairman of the Royal Society of Chemistry’s Heterocyclic and Synthesis Group, Peter O’Brien explores the role of heterocycles in the pharmaceutical industry In 2017, the Royal Society of Chemistry’s Heterocyclic and Synthesis Group celebrated its 50th anniversary. It thus appears timely...
early drug development

IDEAS: improving design, evaluation and analysis of early drug development studies

Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University explores a novel approach to Ph.D. training for those in the pharmaceutical industry
anti-infectives challenge

An international approach to the anti-infectives challenge

Professor Colin Suckling from the University of Strathclyde discusses the need for global collaboration on the anti-infectives challenge.
leukaemia

Living with Leukaemia

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is an umbrella term for cancers of the white blood cells – ‘leuk’ means white and ‘aemia’ refers to a condition of the blood. 26 people are...
early stage cancer

Early stage diagnosis – spotting early stage cancer events

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer
symptoms of Parkinson's

Treatments and symptoms of Parkinson’s

Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure
chemotherapy data

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article
chemical biology

Chemical biology: A chance conversation but an important question

Research professor Prof Colin J Suckling OBE DSc FRSE discusses his engagement with medicinal chemistry and chemical biology

Predicting drug responses

Luminex xTAG® CYP2D6 Kit v3 and xTAG® CYP2C19 Kit v3 assays may aid in determining therapeutic strategies for drugs metabolized by CYP2D6 and CYP2C19 gene products Physicians have long been aware of the subtle differences between patients and their responses to medications. The recognition that a part of this variation...
The role of chemistry in drug discovery and development

The role of chemistry in drug discovery and development

Sriram Radhakrishnan, Healthcare Analyst at Frost & Sullivan details the vital role chemistry plays in drug discovery and development Drug discovery and development is one of the most complex and expensive activities within the framework of the pharmaceutical industry. It encompasses a wide array of end-to-end activities with a plethora...

Follow Open Access Government